EDUARDO PONS-FUSTER LOPEZ
|
López-Jornet P, Pons-Fuster E, Ruiz-Roca JA. YOUTUBE videos on oral care of the organ or hematopoietic stem cell transplant patients. Support Care Cancer. 2017 Apr;25(4):1097-1101. doi: 10.1007/s00520-016-3497-3. Epub 2016 Nov 22. PubMed PMID: 27878369.
AÑO: 2017; IF: 2.676
|
27878369
|
Pons-Fuster López E, Wang QT, Wei W, López Jornet P. Potential chemotherapeutic effects of diosgenin, zoledronic acid and epigallocatechin-3-gallate on PE/CA-PJ15 oral squamous cancer cell line. Arch Oral Biol. 2017 Oct;82:141-146. doi: 10.1016/j.archoralbio.2017.05.023. Epub 2017 Jun 19. PubMed PMID: 28641180.
AÑO: 2017; IF: 2.05
|
|
Pons-Fuster López E, Seoane Leston J, López Jornet P. Epigallocatechin-3-gallate reduces damage to osteoblast-like cells treated with Zoledronic acid. Arch Oral Biol. 2018 Oct;94:27-32. doi: 10.1016/j.archoralbio.2018.06.018. Epub 2018 Jun 20. PubMed PMID: 29945092.
AÑO: 2018; IF: 1.663
|
|
Ruiz-Roca JA, Pons-Fuster E, Lopez-Jornet P. Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson's Disease: A Systematic Review. J Clin Med. 2019 Mar 6;8(3). pii: E317. doi: 10.3390/jcm8030317. Review. PubMed PMID: 30845700; PubMed Central PMCID: PMC6463012.
AÑO: 2019; IF: 3.303
|
|
Pons-Fuster López E, Gómez García F, López Jornet P. Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation. Arch Oral Biol. 2019 May;101:8-12. doi: 10.1016/j.archoralbio.2019.02.018. Epub 2019 Feb 28. PubMed PMID: 30851692.
AÑO: 2019; IF: 1.931
|
Instituto de Investigación Sanitaria Acreditado
Fondo Social Europeo "El FSE Invierte en tu futuro"
Sello de Calidad Europeo "HR Excellence in Research"
Dirección
Pabellón Docente del Hospital
Clínico Universitario Virgen de la Arrixaca - 3ª Planta
C/ Campo 12, 30120 - El Palmar - Murcia, España
Teléfonos
+34 968359767
+34 968381298
El Instituto
Investigación
Actualidad
Convocatorias